Any current/future new fundraising through debt or equity?

The transcript and information on page 19 (and surrounding pages) do not mention any current or planned fundraising through debt or equity for GEM Aromatics Limited. No specific details were provided about raising new capital via debt or equity instruments during the discussed period. The focus is on revenue growth, capacity ramp-up at Dahej, margin improvement, and product diversification rather than capital raising. The company appears to be funding its ongoing capex (approximately INR270 crores for Dahej) through internal accruals and existing resources, as no mention of external fundraisin

Any current/future capex/capital investment/strategic investment?

The company has invested approximately INR 250 crores in the new Dahej facility (Krystal Ingredients), with INR 20-25 crores remaining to be spent. The Dahej facility is designed as a flexible multipurpose manufacturing platform, supporting rapid product transitions and improved asset utilization. The asset turnover target for the Dahej plant is 3x, aiming for INR 750 to INR 800 crores revenue by FY '29 at peak utilization. The ramp-up plan targets 50%-60% utilization by Q1 FY '28, with all products expected to come online by Q1 FY '27. Minimal additional capex is anticipated for optimizing th

Future growth expectations in sales/revenue/volumes?

GEM Aromatics targets revenue of INR1,050 to INR1,100 crores by FY’28 with an EBITDA margin of 16% to 18%. The Dahej (Krystal) facility is expected to ramp up to 50%-60% utilization by Q1 FY’28 and potentially reach peak revenue of INR750 to INR800 crores by FY’29. Krystal's contribution to revenue is projected at INR650 to INR700 crores with the balance from GEM, subject to product mix adjustments. The existing GEM facility is expected to contribute around INR400 crores by FY’28, growing from a Q2/Q3 run-rate of INR320 crores. Growth is backed by capacity ramp-up at Dahej, diversifica

Future growth expectations in earnings/operating earnings/profits/EPS?

The company targets revenue of INR 1,050 to INR 1,100 crores by FY’28 with EBITDA margins of 16% to 18% (Page 19). EBITDA margins are expected to improve as the Krystal plant ramps up; currently, EBITDA margin is around 9% but is projected to increase with capacity utilization (Page 8). Krystal plant is expected to achieve cash breakeven at approximately 45% utilization by next year (FY’27) (Page 10). The Dahej facility (Krystal Ingredients) aims for INR 750 to 800 crores revenue by FY’29, with a 3x asset turnover and 30% free space for expansion (Page 11). Ramp-up at Dahej facility to 50%-60%

Current/ Expected Orderbook/ Pending Orders?

Q4 is historically the strongest quarter for order booking, especially from the US and export markets. Customers have largely depleted inventories over Q2 and Q3, leading to increased inquiries and expected order flows in Q4. The company anticipates a higher volume of orders compared to Q2 and Q3 but is cautious about exact numbers due to various market uncertainties. The ramp-up in cooling agent sales is expected after audits complete by March-April, potentially adding to order inflows. Overall, inquiries and order flows are improving, but timing of revenue recognition may be affected by expo

IN US

Sale is live|00:00:00left today

Gem Aromatics LtdQ4 FY27Chemicals & Petrochemicals

Gem Aromatics Ltd Q4 FY27 Earnings Call Analysis

Revenue, margin, capex, fundraise and order book outlook from management commentary.

Price: ₹185P/E: 29.4Market Cap: ₹867 CrSector: Chemicals & Petrochemicals

Management growth scorecard

Revenue

Category 2

Margin

Category 1

Fundraise

N/A

Order

Yes

Capex

Yes

3 of 4 growth signals are positive.

Full analysis

Revenue guidance

Category 2

→GEM Aromatics targets revenue of INR1,050 to INR1,100 crores by FY’28 with an EBITDA margin of 16% to 18%.
→The Dahej (Krystal) facility is expected to ramp up to 50%-60% utilization by Q1 FY’28 and potentially reach peak revenue of INR750 to INR800 crores by FY’29.
→Krystal's contribution to revenue is projected at INR650 to INR700 crores with the balance from GEM, subject to product mix adjustments.
→The existing GEM facility is expected to contribute around INR400 crores by FY’28, growing from a Q2/Q3 run-rate of INR320 crores.
→Growth is backed by capacity ramp-up at Dahej, diversification of products, and expanding into institutional customers, especially in cooling agents.
→Export recovery is expected with easing tariff impacts and new approvals in major markets like the US and Europe.
→Overall, the company expects gradual improvement in demand, volume, and price realization supporting sustainable growth.

Margin guidance

Category 1

→The company targets revenue of INR 1,050 to INR 1,100 crores by FY’28 with EBITDA margins of 16% to 18% (Page 19).
→EBITDA margins are expected to improve as the Krystal plant ramps up; currently, EBITDA margin is around 9% but is projected to increase with capacity utilization (Page 8).
→Krystal plant is expected to achieve cash breakeven at approximately 45% utilization by next year (FY’27) (Page 10).
→The Dahej facility (Krystal Ingredients) aims for INR 750 to 800 crores revenue by FY’29, with a 3x asset turnover and 30% free space for expansion (Page 11).
→Ramp-up at Dahej facility to 50%-60% utilization is expected by Q1 FY’28, supporting revenue and margin growth (Page 9).
→Gradual easing of near-term uncertainties like tariffs and GST issues is expected to support improved business momentum (Page 17).
→Profit margins will benefit from a shift to higher-margin products and operational efficiencies at the new facility (Pages 8, 10-11).

3 more insights locked — sign up free to unlock

Fundraise plans

→The transcript and information on page 19 (and surrounding pages) do not mention any current or planned fundraising through debt or equity for GEM Aromatics Limited.
→No specific details were provided about raising new capital via debt or equity instruments during the discussed period.
→The focus is on revenue growth, capacity ramp-up at Dahej, margin improvement, and product diversification rather than capital raising.
→The company appears to be funding its ongoing capex (approximately INR270 crores for Dahej) through internal accruals and existing resources, as no mention of external fundraising was made.
→If you need detailed or updated fundraising plans, it is advisable to contact the investor relations team at Stellar Investor Relations as suggested in the document.

Order book

Yes

→Q4 is historically the strongest quarter for order booking, especially from the US and export markets.
→Customers have largely depleted inventories over Q2 and Q3, leading to increased inquiries and expected order flows in Q4.
→The company anticipates a higher volume of orders compared to Q2 and Q3 but is cautious about exact numbers due to various market uncertainties.
→The ramp-up in cooling agent sales is expected after audits complete by March-April, potentially adding to order inflows.
→Overall, inquiries and order flows are improving, but timing of revenue recognition may be affected by export and accounting practices.

Capex plans

Yes

→The company has invested approximately INR 250 crores in the new Dahej facility (Krystal Ingredients), with INR 20-25 crores remaining to be spent.
→The Dahej facility is designed as a flexible multipurpose manufacturing platform, supporting rapid product transitions and improved asset utilization.
→The asset turnover target for the Dahej plant is 3x, aiming for INR 750 to INR 800 crores revenue by FY '29 at peak utilization.
→The ramp-up plan targets 50%-60% utilization by Q1 FY '28, with all products expected to come online by Q1 FY '27.
→Minimal additional capex is anticipated for optimizing the Dahej facility based on product mix and traction.
→The company is also pursuing strategic moves such as consolidation of product lines (e.g., moving clove from GEM to Krystal) to enhance capital efficiency.

How does Gem Aromatics Ltd rank vs peers in Chemicals & Petrochemicals?

Pro feature

1Gem Aromatics Ltd

Rev 2Mar 1

See full Chemicals & Petrochemicals sector rankings

Want more stocks like Gem Aromatics Ltd?

Build an AI portfolio filtered by sector, market cap, and growth rank. Takes 2 minutes.

Build my portfolio